BioPharma Crescent

What BioPharma Crescent does

BioPharma Crescent is a regional economic development initiative — not a commercial product company — that markets a five-county area of Eastern North Carolina (Edgecombe, Johnston, Nash, Pitt, Wilson) to biopharma manufacturers weighing new-plant or expansion siting decisions. Founded in 2018 and headquartered at 106A Barnes St, Wilson, NC, the organization operates with 1-10 staff under Director Carl Rees and coordinates with county economic development offices, the North Carolina Biotechnology Center, ElectriCities, and East Carolina University to deliver a bundled value proposition: pre-qualified industrial sites (Indigreen Corporate Park, Eastfield Crossing, Wilson Corporate Park, Whitaker Business and Industry Center), a workforce pipeline (10,000+ biopharma employees, NC Pharmaceutical Services Network, ECU's Pharmaceutical Development Center of Excellence, community college biologics training facilities), and tiered state/county tax and training incentives on top of documented utility headroom. Revenue model: the entity is funded through public-private partnership rather than product/service sales and does not report revenue. GTM is sales-led, executed via direct outreach by Carl Rees and partner-organization referrals from county EDCs, supplemented by a content-marketing presence (biopharmacrescent.com), industry events (ECU Spring Pharma Conference), and earned media via the NC Biotechnology Center. Tenant-side achievements attributable to the initiative include cumulative capital investment exceeding $3B by companies such as Pfizer (Rocky Mount sterile injectables, ~25% of US supply), Novo Nordisk (Clayton DAPI/DFP), Merck (Wilson packaging), Thermo Fisher/Patheon (Greenville CDMO), Grifols (Clayton plasma derivatives), and SCHOTT Pharma (Wilson prefillable syringes for GLP-1/mRNA therapies).

Name

BioPharma Crescent

Legal name

BioPharma Crescent

Website

https://biopharmacrescent.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

BioPharma Crescent is a public-private regional economic development initiative that markets a five-county area of Eastern North Carolina to biopharma manufacturers, bundling industrial sites, workforce training, utility infrastructure, and state/county incentives to attract and expand pharmaceutical manufacturing investment.

Ownership category

akta.pro rank

Headquarters

HQ city

Greenville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

BioPharma Crescent is a regional economic development partnership that markets a five-county area of Eastern North Carolina to biopharmaceutical manufacturers seeking to locate, expand, or invest in new operations. It provides site selection data, workforce pipeline information, tax and incentive guidance, and utilities/transportation infrastructure resources to prospective biopharma employers. Its flagship asset is the Crescent Park master-planned industrial park, supported by online property databases and customized incentive packaging.

Product overview

BioPharma Crescent is a regional economic development organization, not a unified product platform. It offers a portfolio of site location services, workforce development programs, and incentive consultation to attract biopharma manufacturing companies to Eastern North Carolina. The core offerings include Active Sites (industrial real estate across Eastfield Crossing, Indigreen Corporate Park, Wilson Corporate Park, and Whitaker Business and Industry Center), Workforce Development Services (NC Pharmaceutical Services Network, Eastern Region Pharma Center, Johnston County Workforce Development Center), Taxes and Incentives consultation, Utilities infrastructure information, and Company Profiles of major employers in the region.

Differentiator

Problem solved

Functional benefit

Products and services

• Crescent Park Master-Planned Industrial Park

Quantifiable outcome

• 10,000+ biopharma employees in the five-county region
• +3 more outcomes

Named customers14 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Ten partnerships are on record, tiered core.

• ElectriCitiescoreStrategic or Co-development PartnerElectriCities is a public power strategic partnership that provides economic development services including marketing support for the BioPharma Crescent region. Their Economic Development team coordinates with BioPharma Crescent on publications and outreach efforts.
• Johnston County Economic DevelopmentcoreStrategic or Co-development PartnerJohnston County EDC collaborates with BioPharma Crescent on site selection assistance, workforce development initiatives (Workforce Development Center, JOCO WORKS), and incentive coordination for companies locating or expanding in Johnston County.
• North Carolina Biotechnology CentercoreStrategic or Co-development PartnerNC Biotech Center, through its Eastern Regional Office led by Mark Phillips, provides workforce development programs (Pharma K12), press releases, Bio Jobs Hub platform, and co-marketing for the BioPharma Crescent. Key partner on workforce pipeline initiatives including the Golden LEAF grant for ECU training expansion.
• Wilson Economic Development CouncilcoreStrategic or Co-development PartnerWilson EDC collaborates on marketing Wilson Corporate Park sites, facilitating SCHOTT Pharma's new facility, and coordinating with Wilson Community College on the $40 million biologics training facility investment.
• Pitt County Economic Development CommissioncoreStrategic or Co-development PartnerPitt County EDC manages Indigreen Corporate Park and works with BioPharma Crescent on attracting companies to Greenville, NC. Coordinates with ECU, Pitt Community College, and local utilities for site development.
• East Carolina University (ECU)coreStrategic or Co-development PartnerECU is a key workforce development partner operating the Pharmaceutical Development and Manufacturing Center of Excellence, hosting the annual Pharma Conference, and receiving Golden LEAF grants for pharmaceutical training expansion. Collaborates with Thermo Fisher and Novo Nordisk on curriculum development.
• Pitt Community CollegecoreStrategic or Co-development PartnerPitt Community College provides the PSN@PCC pilot plant manufacturing environment and lab scale equipment for oral solid dosage theory and manufacturing training as part of the NC Pharmaceutical Services Network.
• Johnston Community CollegecoreStrategic or Co-development PartnerPartner in the Johnston County Workforce Development Center (30,000 sq. ft. training facility in Clayton) and in the $1.3 million remodeling of that facility. Collaborates with Novo Nordisk and Grifols on life sciences curricula.
• Wilson Community CollegecoreStrategic or Co-development PartnerWilson Community College is receiving a $40 million investment for a new biologics training facility, enabling workforce training for SCHOTT Pharma and other Wilson-based biopharma companies.
• Thermo Fisher ScientificcoreStrategic or Co-development PartnerThermo Fisher Scientific is both a major employer in the region (Patheon division in Greenville) and a workforce development partner in the Pharma K12 program. The company has invested over $800 million in the region across multiple expansion announcements.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• BioNJ: New Jersey's life sciences trade association representing biopharma companies and supporting cluster growth, workforce, and policy initiatives — a state-level peer with a similar role.
• BioFlorida: Florida's life sciences trade association focused on growing the state's biopharma, medical device, and biotech industry through networking, workforce advocacy, and cluster promotion — a state-level peer with a similar role.
• Georgia Bio: Georgia's statewide organization advancing life sciences industry growth, including biopharma manufacturing. Operates a comparable model of cluster promotion, advocacy, and industry support.
• North Carolina Biotechnology Center: State-level life sciences economic development organization that funds biotech growth, runs workforce programs (including the Bio Jobs Hub), and actively partners with BioPharma Crescent via its Eastern Regional Office. Comparable mission and operating model.
• Life Sciences Pennsylvania: Pennsylvania statewide organization dedicated to advancing the life sciences industry through advocacy, networking, and economic development — closely comparable mission and operating model.

Broad incumbents

• MassBio: Massachusetts life sciences trade and economic development association that promotes cluster growth, workforce development, and policy advocacy for biopharma. Larger and more established, but comparable mission of advancing regional life sciences industry.
• Indiana Economic Development Corporation: Indiana's statewide economic development agency, which has actively recruited biopharma manufacturing (e.g., Eli Lilly expansions). Comparable role in attracting biopharma investment, though it operates across multiple industries.
• Biocom California: California life sciences advocacy and economic development organization representing hundreds of biopharma and biotech members. Comparable function of clustering, workforce, and policy support for a regional life sciences industry.

Regional players

• Maryland Tech Council: Regional life sciences and technology industry association in Maryland focused on cluster growth, workforce development, and advocacy — a comparable state-level peer with overlapping functions.
• Indiana Life Sciences Association (Indiana BioPharma Initiative): Industry association dedicated to advancing Indiana's biopharma manufacturing cluster; competes with BioPharma Crescent for biopharma capex dollars and operates with a comparable workforce-and-cluster-development model.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioPharma Crescent